Author

C. Offenhauser

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:organoid / primary culture· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

B. W. Day· 1 shared B. Wainwright· 1 shared C. Lim· 1 shared G. Stein· 1 shared M. Maybury· 1 shared M. Piper· 1 shared M. Sokolsky-Papkov· 1 shared R. C. J. DSouza· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. W. Day

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting OLIG2 increases therapeutic responses in SHH medulloblastoma mouse models and patient-derived medulloblastoma organoids

Y. Li, T. Dismuke, C. Lim, Z. C. Bruce, C. Offenhauser, U. Baumgartner, M. Maybury, R. C. J. DSouza, T. Hassall, B. Wainwright, G. Stein, M. Piper, T. G. Johns, M. Sokolsky-Papkov, T. R. Gershon, B. W. Day

This study shows that targeting OLIG2 with CT-179 reduces recurrence in SHH medulloblastoma models and improves survival when combined with radiotherapy.

bioRxiv · Feb 14, 2022 · PreprintCancer Biology